{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T08:23:57Z","timestamp":1780388637120,"version":"3.54.1"},"reference-count":47,"publisher":"Termedia Sp. z.o.o.","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Med Sci"],"published-print":{"date-parts":[[2021,5,6]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) was designed to measure the vision-related quality of life (QoL). We aimed to assess the effect of disease duration, disease type (i.e., acute vs. chronic and unilateral vs. bilateral), and selected sociodemographic data on the QoL of patients with central serous chorioretinopathy (CSC).<\/jats:p><\/jats:sec><jats:sec><jats:title>Material and methods<\/jats:title><jats:p>The study included 79 patients diagnosed with CSC. The QoL was assessed using the NEI VFQ-25. The statistical analysis was performed using IBM SPSS Statistics 24.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A significant positive correlation was found between deterioration in peripheral vision as assessed by the NEI VFQ-25 and duration of CSC (r = \u20130.22, p = 0.046). Compared with women, men obtained higher scores on the scales assessing general health, mental health, ocular pain and role limitations (p = 0.018, p = 0.027, p = 0.009 and p = 0.007, respectively). Patients with acute CSC reported higher levels of social functioning as compared with those with chronic CSC (p = 0.04). There were no differences in any of the scales between patients with unilateral and bilateral CSC. Elderly patients obtained lower scores on 9 of the 12 analyzed scales, as compared with younger patients (p &lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Patients with CSC do not assess their QoL in negative terms, which may be related to the fact that the disease presents with transient symptoms. However, the QoL deteriorated with longer disease duration. Men with CSC have better vision-related QoL than women.<\/jats:p><\/jats:sec>","DOI":"10.5114\/aoms.2020.92694","type":"journal-article","created":{"date-parts":[[2020,1,31]],"date-time":"2020-01-31T22:02:16Z","timestamp":1580508136000},"page":"724-730","source":"Crossref","is-referenced-by-count":16,"title":["Quality of life of patients with central serous chorioretinopathy \u2013 a major cause of vision threat among middle-aged individuals"],"prefix":"10.5114","volume":"17","author":[{"given":"Izabella","family":"Karska-Basta","sequence":"first","affiliation":[{"name":"Clinic of Ophthalmology and Ocular Oncology, Department of Ophthalmology, Jagiellonian University, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weronika","family":"Pociej-Marciak","sequence":"additional","affiliation":[{"name":"Clinic of Ophthalmology and Ocular Oncology, Department of Ophthalmology, Jagiellonian University, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micha\u0142","family":"Chrz\u0105szcz","sequence":"additional","affiliation":[{"name":"Clinic of Ophthalmology and Ocular Oncology, University Hospital, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"\u017buber-\u0141askawiec","sequence":"additional","affiliation":[{"name":"Clinic of Ophthalmology and Ocular Oncology, Department of Ophthalmology, Jagiellonian University, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Sanak","sequence":"additional","affiliation":[{"name":"Division of Molecular Biology and Clinical Genetics, Department of Internal Medicine, Jagiellonian University, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo\u017cena","family":"Romanowska-Dixon","sequence":"additional","affiliation":[{"name":"Clinic of Ophthalmology and Ocular Oncology, Department of Ophthalmology, Jagiellonian University, Krakow, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3061","published-online":{"date-parts":[[2021,5,6]]},"reference":[{"key":"ref-518562","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.semnephrol.2015.02.002","article-title":"Endothelin receptors and their antagonists","volume":"3","author":"Maguire JJ","year":"2015","unstructured":"Maguire JJ, Davenport AP. (2015). Endothelin receptors and their antagonists Semin Nephrol. 3: 125-36.","journal-title":"Semin Nephrol"},{"key":"ref-518563","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0014-5793(96)00951-9","article-title":"A molecular model for human Big-Endothelin-1 (Big ET-1)","volume":"394","author":"Peto H","year":"1996","unstructured":"Peto H, Corder R, Janes RW, Wallace BA. (1996). A molecular model for human Big-Endothelin-1 (Big ET-1) FEBS Lett. 394: 191-5.","journal-title":"FEBS Lett"},{"key":"ref-518564","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.vph.2005.03.004","article-title":"Vascular endothelin in hypertension","volume":"43","author":"Schiffrin EL","year":"2005","unstructured":"Schiffrin EL. (2005). Vascular endothelin in hypertension Vascul Pharmacol. 43: 19-29.","journal-title":"Vascul Pharmacol"},{"key":"ref-518565","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1001\/jama.2016.19043","article-title":"Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015","volume":"317","author":"Forouzanfar MH","year":"2017","unstructured":"Forouzanfar MH, Liu P, Roth GA, et al. (2017). Global burden of hypertension and systolic blood pressure of at least 110 to 115 mm Hg, 1990-2015 JAMA. 317: 165-82.","journal-title":"JAMA"},{"key":"ref-518566","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5114\/aoms.2016.59257","article-title":"Red cell distribution width and end-organ damage in patients with systo-diastolic hypertension","volume":"12","author":"Pusuroglu H","year":"2016","unstructured":"Pusuroglu H, Akgul O, Erturk M, et al. (2016). Red cell distribution width and end-organ damage in patients with systo-diastolic hypertension Arch Med Sci. 12: 319-25.","journal-title":"Arch Med Sci"},{"key":"ref-518567","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney PM","year":"2005","unstructured":"Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. (2005). Global burden of hypertension: analysis of worldwide data Lancet. 365: 217-23.","journal-title":"Lancet"},{"key":"ref-518568","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1161\/01.CIR.84.6.2280","article-title":"Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation","volume":"84","author":"Yoshibayashi M","year":"1991","unstructured":"Yoshibayashi M, Nishioka K, Nakao K, et al. (1991). Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation Circulation. 84: 2280-5.","journal-title":"Circulation"},{"key":"ref-518569","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1161\/01.HYP.28.4.652","article-title":"Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension","volume":"28","author":"Ergul S","year":"1996","unstructured":"Ergul S, Parish DC, Puett D, Ergul A. (1996). Racial differences in plasma endothelin-1 concentrations in individuals with essential hypertension Hypertension. 28: 652-5.","journal-title":"Hypertension"},{"key":"ref-518570","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/S0895-7061(96)00259-2","article-title":"Central obesity and hypertension: the role of plasma endothelin","volume":"9","author":"Parrinello G","year":"1996","unstructured":"Parrinello G, Scaglione R, Pinto A, et al. (1996). Central obesity and hypertension: the role of plasma endothelin Am J Hypertension. 9: 1186-91.","journal-title":"Am J Hypertension"},{"key":"ref-518571","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/jc.2006-1819","article-title":"Review: insulin and endothelIn: an interplay contributing to hypertension development?","volume":"92","author":"Sarafidis PA","year":"2007","unstructured":"Sarafidis PA, Bakris GL. (2007). Review: insulin and endothelIn: an interplay contributing to hypertension development? J Clin Endocrinol Metab. 92: 379-85.","journal-title":"J Clin Endocrinol Metab"},{"key":"ref-518572","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ajh.2008.154","article-title":"Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran","volume":"21","author":"Esteghamati A","year":"2008","unstructured":"Esteghamati A, Abbasi M, Alikhani S. (2008). Prevalence, awareness, treatment, and risk factors associated with hypertension in the Iranian population: the national survey of risk factors for noncommunicable diseases of Iran Am J Hypertens. 21: 620-6.","journal-title":"Am J Hypertens"},{"key":"ref-518573","doi-asserted-by":"crossref","first-page":"464","DOI":"10.7326\/0003-4819-114-6-464","article-title":"Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease?","volume":"114","author":"Stewart DJ","year":"1991","unstructured":"Stewart DJ, Levy RD, Cernacek P, Langleben D. (1991). Increased plasma endothelin-1 in pulmonary hypertension: marker or mediator of disease? Ann Intern Med. 114: 464-9.","journal-title":"Ann Intern Med"},{"key":"ref-518574","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/01.HYP.25.6.1135","article-title":"EndothelIn: potential role in hypertension and vascular hypertrophy","volume":"25","author":"Schiffrin EL","year":"1995","unstructured":"Schiffrin EL. (1995). EndothelIn: potential role in hypertension and vascular hypertrophy Hypertension. 25: 1135-43.","journal-title":"Hypertension"},{"key":"ref-518575","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.HYP.0000043680.75107.CF","article-title":"Association of endothelin-1 gene variant with hypertension","volume":"41","author":"Jin JJ","year":"2003","unstructured":"Jin JJ, Nakura J, Wu Z, et al. (2003). Association of endothelin-1 gene variant with hypertension Hypertension. 41: 163-7.","journal-title":"Hypertension"},{"key":"ref-518576","author":"Gene \u2013","unstructured":"Gene \u2013 NCBI. ().   www.ncbi.nlm.nih.gov\/gene\/?term=rs10478694."},{"key":"ref-518577","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1002\/lary.20181","article-title":"Endothelin-1 gene polymorphism and hearing impairment in elderly Japanese","volume":"119","author":"Uchida Y","year":"2009","unstructured":"Uchida Y, Sugiura S, Nakashima T, Ando F, Shimokata H. (2009). Endothelin-1 gene polymorphism and hearing impairment in elderly Japanese Laryngoscope. 119: 938-43.","journal-title":"Laryngoscope"},{"key":"ref-518578","first-page":"208","article-title":"Endothelin-1 and endothelial nitric oxide polymorphisms in idiopathic pulmonary arterial hypertension","volume":"1","author":"Vadapalli S","year":"2010","unstructured":"Vadapalli S, Rani HS, Sastry B, Nallari P. (2010). Endothelin-1 and endothelial nitric oxide polymorphisms in idiopathic pulmonary arterial hypertension Int J Mol Epidemiol Genet. 1: 208-13.","journal-title":"Int J Mol Epidemiol Genet"},{"key":"ref-518579","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/01.HYP.33.5.1169","article-title":"The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people","volume":"33","author":"Tiret L","year":"1999","unstructured":"Tiret L, Poirier O, Hallet V, et al. (1999). The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people Hypertension. 33: 1169-74.","journal-title":"Hypertension"},{"key":"ref-518580","doi-asserted-by":"crossref","first-page":"431","DOI":"10.2337\/diab.44.4.431","article-title":"Plasma endothelin-1 levels in obese hypertensive and normotensive men","volume":"44","author":"Ferri C","year":"1995","unstructured":"Ferri C, Bellini C, Desideri G, et al. (1995). Plasma endothelin-1 levels in obese hypertensive and normotensive men Diabetes. 44: 431-6.","journal-title":"Diabetes"},{"key":"ref-518581","doi-asserted-by":"publisher","DOI":"10.4238\/gmr16037446"},{"key":"ref-518582","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.lfs.2014.04.010","article-title":"Association of endothelin-1 gene polymorphisms with the clinical phenotype in primary nephrotic syndrome of children","volume":"118","author":"Yang F","year":"2014","unstructured":"Yang F, Lai X, Deng L, et al. (2014). Association of endothelin-1 gene polymorphisms with the clinical phenotype in primary nephrotic syndrome of children Life Sci. 118: 446-50.","journal-title":"Life Sci"},{"key":"ref-518583","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1373\/clinchem.2003.025593","article-title":"Identification of twelve polymorphisms in the endothelin-1 gene by use of fluorescently labeled oligonucleotides and PCR with restriction fragment polymorphism analysis","volume":"50","author":"Diefenbach K","year":"2004","unstructured":"Diefenbach K, Arjomand Nahad F, Meisel C, et al. (2004). Identification of twelve polymorphisms in the endothelin-1 gene by use of fluorescently labeled oligonucleotides and PCR with restriction fragment polymorphism analysis Clin Chem. 50: 448-51.","journal-title":"Clin Chem"},{"key":"ref-518584","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0021-9150(00)81153-3","article-title":"An association of three polymorphisms in the gene coding for endothelin-1 (ET-1) in essential hypertension","volume":"151","author":"Vasku A","year":"2000","unstructured":"Vasku A, Izakovicova Holla L, Tschplova S, Muzik J, Soucek M, Vacha J. (2000). An association of three polymorphisms in the gene coding for endothelin-1 (ET-1) in essential hypertension Atherosclerosis. 151: 255.","journal-title":"Atherosclerosis"},{"key":"ref-518585","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ejcdt.2012.09.014","article-title":"The role of the biomarker and the genetic polymorphism of endothelin-1 in pulmonary arterial hypertension among Egyptians","volume":"61","author":"Ibrahima E","year":"2012","unstructured":"Ibrahima E, Kassema A, Zakaria N. (2012). The role of the biomarker and the genetic polymorphism of endothelin-1 in pulmonary arterial hypertension among Egyptians Egypt J Chest Dis Tuberc. 61: 495-500.","journal-title":"Egypt J Chest Dis Tuberc"},{"key":"ref-518586","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11739-011-0643-2","article-title":"Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension","volume":"7","author":"Calabro P","year":"2012","unstructured":"Calabro P, Limongelli G, Maddaloni V, et al. (2012). Analysis of endothelin-1 and endothelin-1 receptor A gene polymorphisms in patients with pulmonary arterial hypertension Intern Emerg Med. 7: 425-30.","journal-title":"Intern Emerg Med"},{"key":"ref-518587","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0895-7061(01)02162-8","article-title":"Endothelin gene variants and aortic and cardiac structurein never-treated hypertensives","volume":"14","author":"Lajemi M","year":"2001","unstructured":"Lajemi M, Gautier S, Poirier O, et al. (2001). Endothelin gene variants and aortic and cardiac structurein never-treated hypertensives Am J Hypertens. 14: 755-60.","journal-title":"Am J Hypertens"},{"key":"ref-518588","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1139\/y03-010","article-title":"Endothelin-1 in atherosclerosis and other vasculopathies","volume":"81","author":"Bousette N","year":"2003","unstructured":"Bousette N, Giaid A. (2003). Endothelin-1 in atherosclerosis and other vasculopathies Can J Physiol Pharmacol. 81: 578-87.","journal-title":"Can J Physiol Pharmacol"},{"key":"ref-518589","doi-asserted-by":"crossref","first-page":"513","DOI":"10.5114\/aoms.2016.59924","article-title":"Adding carotid total plaque area to the Framingham risk score improves cardiovascular risk classification","volume":"12","author":"Perez HA","year":"2016","unstructured":"Perez HA, Garcia NH, Spence JD, Armando LJ. (2016). Adding carotid total plaque area to the Framingham risk score improves cardiovascular risk classification Arch Med Sci. 12: 513-20.","journal-title":"Arch Med Sci"},{"key":"ref-518590","doi-asserted-by":"crossref","first-page":"697","DOI":"10.5114\/aoms.2015.48730","article-title":"Serum paraoxonase 1 activity in patients with iron deficiency anemia","volume":"12","author":"Okuturlar Y","year":"2016","unstructured":"Okuturlar Y, Gedikbasi A, Akalin N, et al. (2016). Serum paraoxonase 1 activity in patients with iron deficiency anemia Arch Med Sci. 12: 697-703.","journal-title":"Arch Med Sci"},{"key":"ref-518591","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/01.CIR.92.9.2426","article-title":"Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans","volume":"92","author":"Lerman A","year":"1995","unstructured":"Lerman A, Holmes DR, Bell MR, Garratt KN, Nishimura RA, Burnett JC. (1995). Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans Circulation. 92: 2426-31.","journal-title":"Circulation"},{"key":"ref-518592","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1161\/01.CIR.88.6.2923","article-title":"Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs","volume":"88","author":"Lerman A","year":"1993","unstructured":"Lerman A, Webster MW, Chesebro JH, et al. (1993). Circulating and tissue endothelin immunoreactivity in hypercholesterolemic pigs Circulation. 88: 2923-8.","journal-title":"Circulation"},{"key":"ref-518593","first-page":"919","article-title":"Endothelin antagonism suppresses plasma and cardiac endothelin-1 levels in SHRSPs at the typical hypertensive stage","volume":"231","author":"Jesmin S","year":"2006","unstructured":"Jesmin S, Zaedi S, Maeda S, et al. (2006). Endothelin antagonism suppresses plasma and cardiac endothelin-1 levels in SHRSPs at the typical hypertensive stage Exp Biol Med. 231: 919-24.","journal-title":"Exp Biol Med"},{"key":"ref-518594","first-page":"985","article-title":"Regulation of endothelin-1 by angiopoietin-1: implications for inflammation","volume":"231","author":"McCarter SD","year":"2006","unstructured":"McCarter SD, Lai PF, Suen RS, Stewart DJ. (2006). Regulation of endothelin-1 by angiopoietin-1: implications for inflammation Exp Biol Med. 231: 985-91.","journal-title":"Exp Biol Med"},{"key":"ref-518595","first-page":"593","article-title":"Correlation between endothelin-1 and atherosclerosis in chronic hemodialysis patients","volume":"23","author":"Liu H","year":"2010","unstructured":"Liu H, Peng Y, Liu F, et al. (2010). Correlation between endothelin-1 and atherosclerosis in chronic hemodialysis patients J Nephrol. 23: 593-602.","journal-title":"J Nephrol"},{"key":"ref-518596","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.5114\/aoms.2015.51177","article-title":"A new diagnostic tool for masked hypertension: impaired sleep quality","volume":"12","author":"Erdem F","year":"2016","unstructured":"Erdem F, Cak\u0131r U, Y\u0131ld\u0131r\u0131m O, et al. (2016). A new diagnostic tool for masked hypertension: impaired sleep quality Arch Med Sci. 12: 1207-13.","journal-title":"Arch Med Sci"},{"key":"ref-518597","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1080\/10623320802228708","article-title":"Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis","volume":"15","author":"Panoulas VF","year":"2008","unstructured":"Panoulas VF, Douglas KM, Smith JP, et al. (2008). Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis Endothelium. 15: 203-12.","journal-title":"Endothelium"},{"key":"ref-518598","doi-asserted-by":"crossref","first-page":"760","DOI":"10.5114\/aoms.2016.58825","article-title":"The effect of antihypertensive treatment on arterial stiffness and serum concentration of selected matrix metalloproteinases","volume":"13","author":"Rajzer M","year":"2017","unstructured":"Rajzer M, Wojciechowska W, Kameczura T, Olszanecka A. (2017). The effect of antihypertensive treatment on arterial stiffness and serum concentration of selected matrix metalloproteinases Arch Med Sci. 13: 760-70.","journal-title":"Arch Med Sci"},{"key":"ref-518599","doi-asserted-by":"crossref","first-page":"552","DOI":"10.5114\/aoms.2016.59928","article-title":"Improvement of survival in Polish stroke patients is related to reduced stroke severity and better control of risk factors: the Krakow Stroke Database","volume":"12","author":"Swarowska M","year":"2016","unstructured":"Swarowska M, Burkot J, Janowska A, et al. (2016). Improvement of survival in Polish stroke patients is related to reduced stroke severity and better control of risk factors: the Krakow Stroke Database Arch Med Sci. 12: 552-55.","journal-title":"Arch Med Sci"},{"key":"ref-518600","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.jacc.2005.05.056","article-title":"Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography","volume":"46","author":"Raff GL","year":"2005","unstructured":"Raff GL, Gallagher MJ, O\u2019Neill WW, Goldstein JA. (2005). Diagnostic accuracy of noninvasive coronary angiography using 64-slice spiral computed tomography J Am Coll Cardiol. 46: 552-7.","journal-title":"J Am Coll Cardiol"},{"key":"ref-518601","first-page":"69","article-title":"Rapid genomic DNA extraction (RGDE)","volume":"1","author":"Ali SM","year":"2008","unstructured":"Ali SM, Mahnaz S, Mahmood T. (2008). Rapid genomic DNA extraction (RGDE) Forensic Sci Int Genet Suppl Ser. 1: 69-75.","journal-title":"Forensic Sci Int Genet Suppl Ser"},{"key":"ref-518602","first-page":"119","article-title":"Endothelin-1 but not endothelial nitric oxide synthase gene polymorphism is associated with sickle cell disease in Africa","volume":"8","author":"Thakur TJ","year":"2014","unstructured":"Thakur TJ, Guindo A, Cullifer LR, et al. (2014). Endothelin-1 but not endothelial nitric oxide synthase gene polymorphism is associated with sickle cell disease in Africa Gene Regul Syst Bio. 8: 119-26.","journal-title":"Gene Regul Syst Bio"},{"key":"ref-518603","first-page":"969","article-title":"Expression of candidate genes associated with obesity in peripheral white blood cells of Mexican children","volume":"12","author":"Ulloa-Mart\u00ednez M","year":"2016","unstructured":"Ulloa-Mart\u00ednez M, Burguete-Garc\u00eda AI, Murugesan S, Hoyo-Vadillo C, Cruz-Lopez M, Garc\u00eda-Mena J. (2016). Expression of candidate genes associated with obesity in peripheral white blood cells of Mexican children Arch Med Sci. 12: 969-76.","journal-title":"Arch Med Sci"},{"key":"ref-518604","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jns.2006.04.007","article-title":"Target-organ damage in adolescent hypertension. Analysis of potential influencing factors, especially nitric oxide and endothelin-1","volume":"247","author":"Katona E","year":"2006","unstructured":"Katona E, Settakis G, Varga Z, et al. (2006). Target-organ damage in adolescent hypertension. Analysis of potential influencing factors, especially nitric oxide and endothelin-1 J Neurol Sci. 247: 138-43.","journal-title":"J Neurol Sci"},{"key":"ref-518605","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.cardiores.2007.06.004","article-title":"The importance of endothelin-1 for vascular dysfunction in cardiovascular disease","volume":"76","author":"B\u00f6hm F","year":"2007","unstructured":"B\u00f6hm F, Pernow J. (2007). The importance of endothelin-1 for vascular dysfunction in cardiovascular disease Cardiovasc Res. 76: 8-18.","journal-title":"Cardiovasc Res"},{"key":"ref-518606","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1161\/HYPERTENSIONAHA.114.03837","article-title":"Nitric oxide inhibition of endothelin-1 release in the vasculature: in vivo relevance of in vitro findings","volume":"64","author":"Rapoport RM","year":"2014","unstructured":"Rapoport RM. (2014). Nitric oxide inhibition of endothelin-1 release in the vasculature: in vivo relevance of in vitro findings Hypertension. 64: 908-14.","journal-title":"Hypertension"},{"key":"ref-518607","first-page":"16858","article-title":"Sympathetic renal denervation in hypertension with chronic kidney disease: a case report and review of literature","volume":"8","author":"Wu Y","year":"2015","unstructured":"Wu Y, Duan S, Qiang X, Ning Z, Xing C, Zhang B. (2015). Sympathetic renal denervation in hypertension with chronic kidney disease: a case report and review of literature Int J Clin Exp Med. 8: 16858-62.","journal-title":"Int J Clin Exp Med"},{"key":"ref-518608","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1254\/jphs.FMJ04006X6","article-title":"Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase\/NO system in atherosclerosis","volume":"96","author":"Kawashima S","year":"2004","unstructured":"Kawashima S. (2004). Malfunction of vascular control in lifestyle-related diseases: endothelial nitric oxide (NO) synthase\/NO system in atherosclerosis J Pharmacol Sci. 96: 411-9.","journal-title":"J Pharmacol Sci"}],"container-title":["Archives of Medical Science"],"original-title":[],"link":[{"URL":"https:\/\/www.archivesofmedicalscience.com\/pdf-115937-64238","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.archivesofmedicalscience.com\/pdf-115937-64238","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T09:37:20Z","timestamp":1626428240000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.archivesofmedicalscience.com\/Quality-of-life-of-patients-with-central-serous-chorioretinopathy-a-major-cause-of,115937,0,2.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,6]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"alternative-id":["115937"],"URL":"https:\/\/doi.org\/10.5114\/aoms.2020.92694","relation":{},"ISSN":["1734-1922","1896-9151"],"issn-type":[{"value":"1734-1922","type":"print"},{"value":"1896-9151","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,6]]}}}